Millennium Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,455,882
| Closed | -$395K | – | 7605 |
|
|
2022
Q3 | $395K | Sell |
1,455,882
-43,242
| -3% | -$18.9K | ﹤0.01% | 5152 |
|
|
2022
Q2 | $1.15M | Sell |
1,499,124
-149,230
| -9% | -$133K | ﹤0.01% | 4237 |
|
|
2022
Q1 | $1.76M | Buy |
1,648,354
+115,161
| +8% | +$209K | ﹤0.01% | 4011 |
|
|
2021
Q4 | $2.91M | Buy |
1,533,193
+316,276
| +26% | +$758K | ﹤0.01% | 3411 |
|
|
2021
Q3 | $3.66M | Sell |
1,216,917
-534,401
| -31% | -$1.9M | ﹤0.01% | 3242 |
|
|
2021
Q2 | $6.85M | Buy |
1,751,318
+841,970
| +93% | +$3.49M | ﹤0.01% | 2348 |
|
|
2021
Q1 | $4.61M | Buy |
909,348
+191,985
| +27% | +$996K | ﹤0.01% | 2661 |
|
|
2020
Q4 | $2.93M | Buy |
717,363
+100,935
| +16% | +$496K | ﹤0.01% | 2918 |
|
|
2020
Q3 | $3K | Sell |
616,428
-388,820
| -39% | -$2.12M | ﹤0.01% | 2281 |
|
|
2020
Q2 | $5.57M | Buy |
1,005,248
+181,260
| +22% | +$830K | 0.01% | 1668 |
|
|
2020
Q1 | $2.7M | Buy |
+823,988
| New | +$4.34M | 0.01% | 1791 |
|
|
2019
Q4 | – | Sell |
-19,168
| Closed | -$79K | – | 4764 |
|
|
2019
Q3 | $79K | Buy |
+19,168
| New | +$69.2K | ﹤0.01% | 3993 |
|
|
2018
Q4 | – | Sell |
-67,278
| Closed | -$491K | – | 4329 |
|
|
2018
Q3 | $491K | Buy |
67,278
+45,865
| +214% | +$201K | ﹤0.01% | 3269 |
|
|
2018
Q2 | $79K | Sell |
21,413
-12,925
| -38% | -$59.8K | ﹤0.01% | 3677 |
|
|
2018
Q1 | $132K | Sell |
34,338
-78,142
| -69% | -$328K | ﹤0.01% | 3448 |
|
|
2017
Q4 | $405K | Sell |
112,480
-104,301
| -48% | -$394K | ﹤0.01% | 3198 |
|
|
2017
Q3 | $856K | Sell |
216,781
-309,447
| -59% | -$1.42M | ﹤0.01% | 2599 |
|
|
2017
Q2 | $2.68M | Buy |
526,228
+251,610
| +92% | +$1.41M | ﹤0.01% | 1909 |
|
|
2017
Q1 | $1.9M | Sell |
274,618
-166,020
| -38% | -$1.3M | ﹤0.01% | 2048 |
|
|
2016
Q4 | $4.12M | Buy |
440,638
+90,908
| +26% | +$819K | 0.01% | 1460 |
|
|
2016
Q3 | $3.42M | Buy |
349,730
+268,078
| +328% | +$3.62M | 0.01% | 1594 |
|
|
2016
Q2 | $1.15M | Sell |
81,652
-49,496
| -38% | -$772K | ﹤0.01% | 2077 |
|
|
2016
Q1 | $1.83M | Sell |
131,148
-52,199
| -28% | -$766K | ﹤0.01% | 1826 |
|
|
2015
Q4 | $3.74M | Sell |
183,347
-165,282
| -47% | -$2.55M | 0.01% | 1552 |
|
|
2015
Q3 | $4.58M | Buy |
348,629
+35,981
| +12% | +$597K | 0.01% | 1390 |
|
|
2015
Q2 | $4.8M | Sell |
312,648
-191,762
| -38% | -$3.68M | 0.01% | 1429 |
|
|
2015
Q1 | $10.1M | Buy |
504,410
+299,525
| +146% | +$6.7M | 0.02% | 1009 |
|
|
2014
Q4 | $4.31M | Buy |
+204,885
| New | +$4.17M | 0.01% | 1490 |
|
|
2014
Q3 | – | Sell |
-32,468
| Closed | -$750K | – | 4090 |
|
|
2014
Q2 | $750K | Buy |
+32,468
| New | +$572K | ﹤0.01% | 2363 |
|
Millennium Management's AGTC Position: Q4 2022 in Review
Millennium Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,455,882 shares — an estimated $395K sold.
Millennium Management first reported a position in AGTC in Q2 2014 and held it in 29 quarters. The position peaked at $10.1M in Q1 2015. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Millennium Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Millennium Management sold 1,455,882 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $395K.
- Millennium Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 29 quarters.
- Millennium Management's Applied Genetic Technologies Corporation position peaked at $10.1M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.